Karen Akinsanya

From WikiAlpha
Revision as of 18:44, 8 May 2024 by Tworighthands (Talk | contribs) (page for a known scientist and researcher)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Akinsanya
Born England
Education Queen Mary College, University of London; Imperial College, University of London
Occupation Biomedical research scientist
Known for President of R&D, Therapeutics at Schrödinger

Karen Akinsanya is a biomedical scientist and pharmaceutical researcher.[1] She is the President of R&D, Therapeutics at Schrödinger.[2][3] She is also the founder of New Jersey-based My Tech Learning.[4]

References

  1. ↑ Twenty extraordinary women in biopharma R&D who worked their way to the top | EndPoints News | November 11, 2019
  2. ↑ AlphaFold could be DeepMind’s AI assistant for drug discovery | WIRED | January 30, 2024
  3. ↑ Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery | Genetic engineering and Biotechnology News | August 18, 2023
  4. ↑ SNautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors | Globe Newswire | March 31, 2022
Retrieved from "http://en.wikialpha.org/mediawiki/index.php?title=Karen_Akinsanya&oldid=516976"